businesspress24.com - Biotech: Pressemitteilungen - Kategorie - Seite 219
 

Biotech

Category / Pharmaceuticals & Biotech / Biotech


REGiMMUNE Initiates Phase I/II Clinical Trial for GvHD

TOKYO: Company Raises 5 Million Dollars in Series A Preferred to Fund Trial ...

Medivation and Astellas Announce Positive Results From the Phase 3 AFFIRM Trial of MDV3100 in Prostate Cancer Patients Who Received Prior Chemotherapy

SAN FRANCISCO, CA and TOKYO: MDV3100 Prolonged Life by 4.8 Months Compared to Placebo and Met All Secondary Endpoints Medivation to Host Conference Call at 4:30PM Eastern Time on Thursday, February 2 ...

Radiopharmaceutical for Targeted Treatment of Prostate Cancer to Enter Clinical Trials

HAMILTON, ON and CAMBRIDGE, MA: Canadian Centre of Excellence Partners With US-Based Molecular Insight Pharmaceuticals to Manufacture a New Radiopharmaceutical for Clinical Trials That Will Evaluate the Potential to Deliver Targeted ...


Page 219 von 247:  « ..  218 219 220  221  222  223  224  225  226  227  .. » 247





 

Who is online

All members: 10 568
Register today: 1
Register yesterday: 2
Members online: 0
Guests online: 85


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.